Cellular and humoral immune response to SARS-CoV-2 mRNA vaccines in patients treated with either Ibrutinib or Rituximab
接受伊布替尼或利妥昔单抗治疗的患者对SARS-CoV-2 mRNA疫苗的细胞和体液免疫反应
期刊:Clinical and Experimental Medicine
影响因子:3.5
doi:10.1007/s10238-022-00809-0
Bacova, Barbora; Kohutova, Zuzana; Zubata, Ivana; Gaherova, Lubica; Kucera, Petr; Heizer, Tomas; Mikesova, Marcela; Karel, Tomas; Novak, Jan